Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
04/2008
04/23/2008EP1421827A4 Organic light emitting devices having carrier blocking layers comprising metal complexes
04/23/2008EP1303483B1 Novel thiourea derivatives and the pharmaceutical compositions containing the same
04/23/2008EP1216230B1 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists
04/23/2008EP1007033B1 Lymphocyte function antigen-1 antagonists
04/23/2008EP0998459B1 Pyridine derivatives
04/23/2008EP0984928B1 Heterocyclic nitrato derivatives
04/23/2008CN101166725A Pyridylacetic acid compound
04/23/2008CN101166724A Sulfonylamino(thio)carbonyl compounds in the form of herbicides or plant growth regulators
04/23/2008CN101166722A Process for preparing 3,3-disubstituted oxindoles and thio-oxindoles
04/23/2008CN101166576A Catalyst precursor for the production of olefins with an odd number of carbon atoms, process for its preparation and production method for such olefins
04/23/2008CN101165061A Hetero triazine compounds
04/23/2008CN101165054A Method for synthesizing 1-hydroxy-1,2,4,5-tetrapyridylcyclohexane
04/23/2008CN100383141C Pyrazolo [4,3-d] pyrimidine derivatives
04/23/2008CN100383123C 4-hydroxylic pyridine and production process thereof
04/23/2008CN100383110C Chiral arylketones in the treatment of neutrophil-dependent inflammatory diseases
04/22/2008US7361787 Prophylaxis of respiratory disorders and therapy, also metod of synthesis and composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent
04/22/2008US7361773 dealkylation of a benzodioxane aniline in presence of chloroethanol
04/22/2008US7361679 Integrin VLA-4 ( alpha 4 beta 1) and/or integrin LPAM-1 ( alpha 4 beta 7) antagonists, cell adhesion inhibitor; bioavailability, oral administration;treating inflammatory diseases; e.g. 3-[2-(2,6-dichlorobenzoylamino)pyrid-5-yl]-2-{3-[(2,2-dimethylpropionyl)isobutylamino]-4-methoxyphenyl}propionic acid
04/22/2008US7361674 7, 8 and 9-substituted tetracycline compounds
04/22/2008US7361671 E.g.,(6-Ethyl-3-(4,5,7-trifluoro-benzothiazol-2-ylmethyl)-pyrr (2,3-b)pyridin-1-yl)acetic acid; interacts with and inhibits aldose reductase; antidiabetic agents and diabetic complications; gout; hypoglycemic and antiarthritic
04/22/2008US7361655 Pharmaceutically effective compounds
04/22/2008US7361198 oxidative hair colorants; which particularly in combination with the often used p-phenylenediamines would give blue shades and afford oxidation colorants with high resistance to external influences, particularly to frequent washing and sunlight
04/22/2008CA2388759C Substituted piperazine derivatives, the preparation thereof and their use as medicaments
04/22/2008CA2180816C 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
04/17/2008WO2008046003A2 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
04/17/2008WO2008045671A1 Matrix metalloprotease inhibitors
04/17/2008WO2008044767A1 Aromatic amine derivative and use thereof
04/17/2008WO2008044713A1 Substituted pyridinecarboxanilide derivative or salt thereof, and agricultural or horticultural agent, and use thereof
04/17/2008WO2008044700A1 GSK-3β INHIBITOR
04/17/2008WO2008044339A1 Therapeutic/preventive agent for intraocular disease containing statin compound
04/17/2008WO2008044217A2 2-aminocarbonyl-pyridine derivatives
04/17/2008WO2008044099A1 Charge transfer complexes in the treatment of inflammatory bowel diseases
04/17/2008WO2008043492A1 Method for producing alkaline (meth)acrylamides
04/17/2008WO2008043446A1 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl)]carbamoyl}amino)-3-fluorophenoxy]-n-methylpyridine-2-carboxamide monohydrate
04/17/2008WO2008022164A3 Pyrazine compounds, their use and methods of preparation
04/17/2008WO2008022046A3 Dicer substrate rna peptide conjugates and methods for rna therapeutics
04/17/2008WO2008011117A3 Antiviral protease inhibitors
04/17/2008WO2007146323A3 Substituted cyanopyridines as protein kinase inhibitors
04/17/2008WO2007115836A3 Tetrahydronaphtol-derivatives and use thereof
04/17/2008WO2007056517A3 Pharmaceutical salts and polymorphs of n- (5-chl0r0-2-pyridinyl) -2- [ [4- [ (dimethylamino) iminomethyl] benzoyl] amino] -5-meth oxy-benzamide, a factor xa inhibitor
04/17/2008US20080091010 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; antiviral and antitumor agents
04/17/2008US20080090996 Thrombopoietin mimetics
04/17/2008US20080090875 Analgesics, antipyretics, antiinflammatory agents; 4-(4-chlorophenyl)-5-(4-methanesulfonylphenyl)-1,2-dihydropyrazole-3-thione for example; cyclooxygenase-2 (COX-2) inhibitors; side effect reduction
04/17/2008US20080090863 Melanin Concentrating Hormone (MCH) receptor antagonists; eating disorder, obesity, psychological disorders, drug addiction, diabetes, cardiovascular disorders; 2-(cyclohexyl(alkyl)amino)pyridines such as 3-chloro-4-fluoro-N-(cis-4-[(4-methoxypyridin-2-yl)amino]cyclohexyl)benzamide
04/17/2008US20080090857 Statin derivatives
04/17/2008US20080090856 useful for the modulation of kinase activity of C-Abl, c-Kit, VEGFR, PDGFR, Flt-3, c-MET, HER family, Raf kinase family and disease polymorphs thereof; hyperproliferative diseases, cancer; 1-(5-(4-(1H-pyrazol-4-yl)pyrimidin-2-yloxy)-2-fluorophenyl)-3-(3-isopropyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl)urea
04/17/2008US20080090854 Cxcr2 inhibitors
04/17/2008US20080090846 Chemokine receptor binding heterocyclic compounds
04/17/2008US20080090842 Novel pyridyl cyanoguanidine compounds
04/17/2008US20080090829 5-{2-[2-(4-Tert-Butyl- phenyl)-oxazol-4-yl]-ethylsulfamoyl}-2-methyl-benzoic acid methyl ester; used as peroxisome proliferator activator receptor agonist, to increase high density lipoproteins and lower LDL-cholesterol and triglycerides; treatment of atherosclerosis, cardiovascular, metabolic disorders
04/17/2008US20080090822 Piperazine Derivatives As Glyt 1 Inhibitors
04/17/2008US20080090794 Potassium Channel Inhibitors
04/17/2008US20080090787 Thrombopoietin mimetics
04/17/2008US20080090782 Inhibit DNA-dependent protein kinase; reduced side effects caused by radiation and chemotherapy drugs
04/17/2008CA2666171A1 Method for producing basic (meth)acrylamides
04/17/2008CA2666170A1 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-n-methylpyridine-2-carboxamide monohydrate
04/17/2008CA2664579A1 2-aminocarbonyl-pyridine derivatives
04/16/2008EP1911776A1 Polyacrylamide gel for electrophoresis, polyacrylamide gel electrophoresis method using the same, method of producing the same and acrylamide compound
04/16/2008EP1911762A1 Amino alcohols and their use as renin inhibitors
04/16/2008EP1911751A1 Amide derivative and pesticide containing such compound
04/16/2008EP1911746A1 The substance having antioxidant, geroprotective and anti-ischemic activity and method for preparing thereof
04/16/2008EP1911740A1 Potassium channel modulators
04/16/2008EP1910304A2 Therapeutic agents
04/16/2008EP1910295A1 Substituted pyridocarboxamides as inhibitors of plasminogen activator inhibitor 1 (pai-1)
04/16/2008EP1910294A1 A process for the preparation of substituted phenyl ether compounds and rosiglitazone
04/16/2008EP1910293A1 Isotopically substituted proton pump inhibitors
04/16/2008EP1910279A2 Non-nucleoside anti-hepacivirus agents and uses thereof
04/16/2008EP1910277A1 Quadratic acid derivatives in the form of a protein kinase inhibitors
04/16/2008EP1910272A1 Renin inhibitors
04/16/2008EP1909572A2 Potassium channel inhibitors
04/16/2008EP1529240A4 Electrolytes for electrooptic devices comprising ionic liquids
04/16/2008CN101163678A 吡啶基甲基砜衍生物 Pyridyl methyl sulfone derivative
04/16/2008CN101163669A Acetylene derivatives
04/16/2008CN101163667A Phenyl ethyne compounds
04/16/2008CN101163662A Phenylacetylene derivatives having mglur5 receptor affinity
04/16/2008CN101161653A Method for preparing novel Pranoprofen key intermediates
04/16/2008CN101161641A Tricyclic steroid hormone nuclear receptor modulators
04/16/2008CN101161343A A novel catalyst for synthesizing pyridine base as well as its preparing and using method
04/16/2008CN100381424C Biaryl sulfonamides and methods for using same
04/16/2008CN100381418C Gelling agents
04/16/2008CA2683910A1 Novel vanilloid receptor ligands and the use thereof for the production of pharmaceuticals
04/15/2008USRE40245 Gyrase inhibitors and uses thereof
04/15/2008US7358397 By cleavage and reduction of a halogenated p-hydroxyazobenzene formed by diazotizing an aniline and reacting with a halogenated phenol; intermediates for fluoro-containing agrochemicals or chronic bronchitis agents
04/15/2008US7358359 Antibacterial agents
04/15/2008US7358264 Statine derivatives for the treatment of Alzheimer's disease
04/15/2008US7358257 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, antithrombotic agents
04/15/2008CA2411468C Thrombopoietin mimetics
04/15/2008CA2276012C 6-(nonsubstituted or substituted) phenoxy picolinic acid, process for producing the same and agricultural or horticultural fungicide using the same
04/15/2008CA2211981C Production of enantiomerically enriched ortho-substituted .alpha.,.alpha.-diaromatic methanols
04/10/2008WO2008042429A1 Improved electrochemical reduction of halogenated 4-aminopicolinic acids
04/10/2008WO2008041751A1 Pharmaceutical preparation for treating fibromyalgia
04/10/2008WO2008041090A1 Malanin concentrating hormone receptor-1 antagonist pyridinones
04/10/2008WO2008041088A2 N-hydroxy benzamides with antitumor activity
04/10/2008WO2008040934A1 Hdac inhibitors
04/10/2008WO2008040651A1 3-pyridinecarboxamide and 2-pyrazinecarboxamide derivatives as hdl-cholesterol raising agents
04/10/2008WO2007136875A3 Acetamide derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
04/10/2008WO2007107345A3 PROCESS FOR PREPARING l-HALO-2,7-NAPHTHYRIDINYL DERIVATIVES
04/10/2008US20080085924 Amidobiphenyloxime derivatives, useful as fungicide or bactericide for protection of crops and materials
04/10/2008US20080085900 Sulfonylguanidine compounds and pharmaceutical uses thereof
04/10/2008US20080085894 Alpha-(n-sulfonamido)acetamide derivatives as beta-amyloid inhibitors